Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01695694 · ClinicalTrials.gov registry record · NA

Violence and HIV Risk Among Women

A NA study, sponsored by University of Rochester.

Completed
Registry status
NA
Development phase
120
Enrollment target

NCT01695694: Completed NA study, sponsored by University of Rochester.

NCT01695694 is a NA study that has completed, run by University of Rochester. The registered enrollment target is 120 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01695694, a NA study, has completed, sponsored by University of Rochester.

COMPLETED
Registry status
NA
Development phase
120 participants
Enrollment target

Study Summary

The purpose of the study is to test the feasibility, acceptability, and efficacy of an adapted intervention that is theoretically and empirically guided by the Information-Motivation-Behavioral skills model (IMB) and aims at reducing sexual risk behavior among women who have experienced Intimate Partner Violence (IPV), as well as such an intervention.

Primary Outcome

Sexual risk behavior is assessed by self-reported number sexual partners in the last three months and number of episodes of unprotected sex with each partner

Interventions

  • BEHAVIORAL supporting positive and healthy relationships
  • BEHAVIORAL community support group

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2012-09
Est. Completion 2013-10
Phase NA
University of Rochester

636 total trials

What the finished NCT01695694 record still lists

NCT01695694 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).

The record links to 0 conditions, and to 2 interventions - of which supporting positive and healthy relationships is the first listed.

NCT01695694 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01695694 about?

NCT01695694 is a clinical study titled "Violence and HIV Risk Among Women". The purpose of the study is to test the feasibility, acceptability, and efficacy of an adapted intervention that is theoretically and empirically guided by the Information-Motivation-Behavioral skills model (IMB) and aims at reducing sexual risk behavior among women who have experienced Intimate Par...

What is the current status of trial NCT01695694?

This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2012-09. Estimated completion is 2013-10.

What interventions are being tested in trial NCT01695694?

The interventions under investigation include: supporting positive and healthy relationships (BEHAVIORAL), community support group (BEHAVIORAL).

Who is sponsoring clinical trial NCT01695694?

This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01695694's enrollment target sits among peer trials

120 762nd of 2000 higher than 1,198 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01174108 · 120 participants · Phase 2

    Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

  • NCT01627301 · 120 participants · NA

    Sympathetic Overactivity in Post-traumatic Stress Disorder

  • NCT02025023 · 120 participants · Phase 3

    Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study

  • NCT02128906 · 120 participants · Phase 2

    Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01695694, the US trial registry maintained by the National Library of Medicine. NCT01695694 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.